Juleber Kit
Product Images NDC 16714-464

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Juleber (NDC 16714-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structures of the active ingredients desogestrel and ethinyl estradiol. The image shows molecular diagrams for both compounds with their respective molecular formulas, C22H30O for desogestrel and C20H24O2 for ethinyl estradiol.*

FDA Label Image

Imgae-02 (Image 02)

A bar chart illustrating circulatory disease mortality rates per 100,000 women-years by age group (15-24, 25-34, 35-44, 45+) with categories for oral contraceptive users and controls, separated by smoking status (non-smokers and smokers). The chart shows mortality rate on the y-axis and age on the x-axis, comparing ever-users and controls in both smokers and non-smokers.*

FDA Label Image

Image-03 (Image 03)

A warning text panel advising not to use Juleber if you smoke cigarettes and are over 35 years old, highlighting increased risks of serious cardiovascular side effects, including heart attack, blood clots, or stroke, from combination oral contraceptives. It notes that the risk increases with age and the number of cigarettes smoked.*

FDA Label Image

Image-04 (Image 04)

Juleber kit blister card showing a 28-tablet supply with three rows of orange active tablets and one row of white inactive tablets. The card includes dosage instructions to take orange tablets first, weekly separation, and storage guidance. Labeler is Northstar Rx LLC.*

FDA Label Image

Image-05 (Image 05)

An instructional illustration showing how to pick and place the correct day label on a Juleber tablet kit. It depicts a hand peeling a day label strip with days of the week to be aligned on the kit, which contains rows of orange (active) and white (inactive) round tablets arranged by week and day.*

FDA Label Image

Image-06 (Image 06)

A warning text panel advising that Juleber should not be used by individuals who smoke cigarettes and are over 35 years old, due to increased risk of serious cardiovascular side effects such as heart attack, blood clots, or stroke from combination oral contraceptives. The risk increases with age and the number of cigarettes smoked.*

FDA Label Image

Image-07 (Image 07)

Juleber kit packaging label showing a 28-tablet blister card with day markings (SUN to SAT) and week numbers (1 to 4). It includes orange active tablets and white inactive tablets, indicating a dosing schedule. The label lists active ingredients as Desogestrel and Ethinyl Estradiol with strengths of 0.15 mg and 0.03 mg respectively. Manufacturer is Northstar Rx LLC.*

FDA Label Image

Image-08 (Image 08)

Instructional illustration showing how to select and peel a day label strip (MON through SUN) to place on a blister pack of Juleber tablets. The diagram indicates the placement of the label and shows an example blister pack with rows of active (orange) and inactive (white) tablets, along with dosing instructions and monthly self-exam reminders.*

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Image-10 (Image 10)

Packaging label for Juleber, a kit containing Desogestrel and Ethinyl Estradiol tablets, USP, with strengths of 0.15 mg and 0.03 mg respectively. The label shows it contains 6 blister cards with 28 tablets each. The product is labeled for prescription use only and is distributed by Northstar Rx LLC. The label includes a blue flower graphic and relevant identification numbers including NDC 16714-464.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.